On September 16, 2026, IDEXX Laboratories, Inc. (Nasdaq: IDXX), a Westbrook, Maine-based provider of veterinary diagnostics, software and information technology products, announced the acquisition of CoVetAI Inc. (CoVet), a Toronto-based provider of AI-native ambient listening and clinical workflow software for veterinary practices. CoVet's platform helps veterinary teams automatically capture and organize information across the patient care journey, from consultation to treatment planning and client follow-up, reducing documentation burden and saving clinicians' time. The acquisition is intended to expand the value of IDEXX's software, diagnostics and AI offerings by making information more accessible, actionable and connected across the practice. CoVet will be integrated into IDEXX's existing software ecosystem, which will continue to support other ambient scribe solutions and third-party practice management systems. Financial terms of the transaction were not disclosed. Osler, Hoskin & Harcourt LLP advised CoVet with a multi-practice-group team covering corporate, competition/antitrust and foreign investment, privacy and data management, employment and labour, technology, intellectual property, and pensions and benefits matters. The deal follows a September 2025 growth-funding round for CoVet led by Off Leash Capital.